Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel polymeric micelles plus gemcitabine in metastatic pancreatic cancer
NCT06752811Phase 3Recruiting
- Sponsor
- Shanghai Yizhong Pharmaceutical Co., Ltd.
- Start
- Feb 2025
- Primary completion
- Jul 2027
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection, sponsored by Shanghai Yizhong Pharmaceutical Co., Ltd.. Started Feb 2025; status: recruiting.
02
Drugs
Paclitaxel Micelles for Injection
Beyond the preview
Go deeper on NCT06752811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06752811.